These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 30152195)
1. Folates in Trypanosoma brucei: Achievements and Opportunities. Cullia G; Tamborini L; Conti P; De Micheli C; Pinto A ChemMedChem; 2018 Oct; 13(20):2150-2158. PubMed ID: 30152195 [TBL] [Abstract][Full Text] [Related]
2. Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis. Jones AJ; Kaiser M; Avery VM Antimicrob Agents Chemother; 2015 Dec; 60(3):1859-61. PubMed ID: 26666915 [TBL] [Abstract][Full Text] [Related]
3. Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei. Faria J; Moraes CB; Song R; Pascoalino BS; Lee N; Siqueira-Neto JL; Cruz DJ; Parkinson T; Ioset JR; Cordeiro-da-Silva A; Freitas-Junior LH J Biomol Screen; 2015 Jan; 20(1):70-81. PubMed ID: 25342146 [TBL] [Abstract][Full Text] [Related]
4. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda. Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of dibenzylideneacetone analogs against the neglected disease pathogen, Trypanosoma brucei. Francisco KR; Monti L; Yang W; Park H; Liu LJ; Watkins K; Amarasinghe DK; Nalli M; Roberto Polaquini C; Regasini LO; Eduardo Miller Crotti A; Silvestri R; Guidi Magalhães L; Caffrey CR Bioorg Med Chem Lett; 2023 Feb; 81():129123. PubMed ID: 36608774 [TBL] [Abstract][Full Text] [Related]
6. Do we need new drugs against human African trypanosomiasis? Stich A; Ponte-Sucre A; Holzgrabe U Lancet Infect Dis; 2013 Sep; 13(9):733-4. PubMed ID: 23969207 [No Abstract] [Full Text] [Related]
7. Evaluating the impact of targeting livestock for the prevention of human and animal trypanosomiasis, at village level, in districts newly affected with T. b. rhodesiense in Uganda. Hamill L; Picozzi K; Fyfe J; von Wissmann B; Wastling S; Wardrop N; Selby R; Acup CA; Bardosh KL; Muhanguzi D; Kabasa JD; Waiswa C; Welburn SC Infect Dis Poverty; 2017 Feb; 6(1):16. PubMed ID: 28162093 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting. Lüscher A; de Koning HP; Mäser P Curr Pharm Des; 2007; 13(6):555-67. PubMed ID: 17346174 [TBL] [Abstract][Full Text] [Related]
9. Antitrypanosomal Chloronitrobenzamides. Carrillo AK; Kadayat TM; Hwang JY; Chen Y; Zhu F; Holbrook G; Gillingwater K; Connelly MC; Yang L; Kaiser M; Guy RK J Med Chem; 2024 Mar; 67(5):3437-3447. PubMed ID: 38363074 [TBL] [Abstract][Full Text] [Related]
10. Discovery of an orally active nitrothiophene-based antitrypanosomal agent. Ajayi O; Metibemu DS; Crown O; Adeyinka OS; Kaiser M; Shoji N; Silva M; Rodriguez A; Ogungbe IV Eur J Med Chem; 2024 Jan; 263():115954. PubMed ID: 37984297 [TBL] [Abstract][Full Text] [Related]
11. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug. Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820 [TBL] [Abstract][Full Text] [Related]
12. Control and surveillance of human African trypanosomiasis. World Health Organization World Health Organ Tech Rep Ser; 2013; (984):1-237. PubMed ID: 24552089 [TBL] [Abstract][Full Text] [Related]
13. Novel 4-[4-(4-methylpiperazin-1-yl)phenyl]-6-arylpyrimidine derivatives and their antitrypanosomal activities against T.brucei. Taylor AE; Hering M; Elsegood MRJ; Teat SJ; Weaver GW; Arroo RRJ; Kaiser M; Maeser P; Bhambra AS Bioorg Med Chem Lett; 2024 Sep; 109():129825. PubMed ID: 38823730 [TBL] [Abstract][Full Text] [Related]
15. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro. Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621 [TBL] [Abstract][Full Text] [Related]
16. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis. Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695 [TBL] [Abstract][Full Text] [Related]
17. Flavonoid-derived Privileged Scaffolds in anti-Trypanosoma brucei Drug Discovery. Boniface PK; Elizabeth FI Curr Drug Targets; 2019; 20(12):1295-1314. PubMed ID: 31215385 [TBL] [Abstract][Full Text] [Related]
18. Whole-organism high-throughput screening against Trypanosoma brucei brucei. Jones AJ; Avery VM Expert Opin Drug Discov; 2013 May; 8(5):495-507. PubMed ID: 23540598 [TBL] [Abstract][Full Text] [Related]
19. In vivo efficacies of 5'-methylthioadenosine analogs as trypanocides. Bacchi CJ; Sanabria K; Spiess AJ; Vargas M; Marasco CJ; Jimenez LM; Goldberg B; Sufrin JR Antimicrob Agents Chemother; 1997 Oct; 41(10):2108-12. PubMed ID: 9333033 [TBL] [Abstract][Full Text] [Related]
20. In vitro Anti-Trypanosomal Activities of Indanone-Based Chalcones. Beteck RM; Legoabe LJ; Isaacs M; Hoppe HC Drug Res (Stuttg); 2019 Jun; 69(6):337-341. PubMed ID: 30452077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]